Unibio USA ApS: Financial statements 2020
CVR: 38179845
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -14,000 and a net result of DKK -11,000 compared with DKK -12,000 the year before. Equity in the 2020 report amounted to DKK 8,000. The solvency ratio was 40%.
- Gross Profit
- DKK -14,000
- Profit/Loss
- DKK -11,000
- Equity
- DKK 8,000
- Total Assets
- DKK 20,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -14K | -11K | 8K | 0 |
| 2019 | - | -15K | -12K | 19K | 0 |
| 2018 | - | -15K | -12K | 31K | 0 |
Official annual report
How creditworthy is Unibio USA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Unibio USA ApS has published its annual report for 2019. Gross profit came to DKK -15,000, and the net result was DKK -12,000.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Søren Olrik Eklund. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000.